Expensify Announces Q2 2024 Results
Interchange derived from the Expensify Card grew to
A Message From Our Founder
I'm extremely pleased with how well Q2 has extended Q1's achievements and improved upon them further:
- Our core business has been stabilize, with increasing cash flow. Revenue and paid users are within 1% of last quarter – with quarterly interchange, operating cash flow, and free cash flow up 14%, 168% and 10% (48%, 2,247% and 399% y/y), respectively.
- The new Expensify Card program is live. Most active Expensify Card customers have already adopted the new program, and 34% of spend has already migrated to the new cards we've mailed out – which earns us 20% more interchange, and contributes directly to revenue. We are well on the way to our target of 100% adoption by EOY.
-
New
Expensify is live. We have returned to the conference circuit after a multi-year absence, with all messaging and demos focused exclusively on New Expensify. Development is no longer solely core development and now includes pipeline optimizations, and New Expensify is expected to add new revenue in Q3. We continue to make brisk progress on the combined business/consumer superapp experience in anticipation of our extremely visible product placement within Apple TV's biggest budget movie ever, scheduled to be in theatersJune 2025 . - Hybrid app is live. This is an incredibly difficult and important technical milestone that allows us to upgrade existing apps deployed on millions of devices worldwide in order to switch interchangeably between New Expensify and Expensify Classic. This is a critical tool for seamlessly migrating existing customers on a selective basis to the new experience, while allowing existing customers with classic functionality that has not yet been updated to remain on their existing experience. The hybrid app is being rolled out globally.
-
Expensify Travel is live. We have launched our travel product to new and existing customers, and is expected to generate an entirely new revenue stream of travel bookings in Q3.
This quarter did a fantastic job laying a clear foundation for future growth, and the excitement inside our (virtual) halls is palpable. Hit me up at our booth at Xerocon or SuiteWorld to see the New Expensify pitch in person!
-david
Founder and CEO of
Second Quarter 2024 Highlights
Financial:
-
Revenue was
$33.3 million , a decrease of 14% compared to the same period last year. -
Generated
$9.3 million cash from operating activities. -
Free cash flow was
$5.7 million . -
Net loss was
$2.8 million , compared to$11.3 million for the same period last year. -
Non-GAAP net income was
$5.6 million . -
Adjusted EBITDA was
$10.2 million . -
Interchange derived from the Expensify Card grew to
$4.0 million , an increase of 48% compared to the same period last year. -
See Financial Outlook section for Free Cash Flow guidance for fiscal year ending
December 31, 2024 .
Business:
- Paid members - Paid members were 684,000, a decrease of 8% from the same period last year.
- New Expensify Card program - The majority of active Expensify Card customers began transitioning to the new program, with 34% of spend migrated by end of Q2.
-
New
Expensify - The company began supporting businesses on New Expensify that is expected to generate revenue beginning in Q3 2024. -
New Integrations -
Expensify launched integrations with QuickBooks Online and Xero on New Expensify, a major milestone to support customers on the new platform. -
Sales and marketing - The company announced a partnership with Apple for lead product placement in Apple's largest feature film investment ever, F1, set to release in
June 2025 . -
Corporate travel - The company returned to the travel conference circuit to demo
Expensify Travel — its corporate travel management platform built for the midsized and small-cap enterprise market — at GBTA, the world's foremost corporate travel event.
Financial Outlook
Free Cash Flow
The Company does not provide a reconciliation for free cash flow estimates on a forward-looking basis because it is unable, without making unreasonable efforts, to provide a meaningful or reasonably accurate calculation or estimation of net cash provided by operating activities and certain reconciling items on a forward-looking basis, which could be significant to the Company's results.
Stock Based Compensation
An estimate of expected stock-based compensation for the next four fiscal quarters is as follows, which is driven primarily by the pre-IPO grant of RSUs issued to all employees (which vest quarterly over eight years with approximately five years remaining).
Est. stock-based compensation (millions) |
|||||||||||||||||||||||
|
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
|||||||||||||||||||
|
Low |
High |
Low |
High |
Low |
High |
Low |
High |
|||||||||||||||
Cost of revenue, net |
$ |
2.4 |
$ |
3.1 |
$ |
2.3 |
$ |
3.0 |
$ |
2.2 |
$ |
2.9 |
$ |
1.9 |
$ |
2.6 |
|||||||
Research and development |
|
3.2 |
|
4.0 |
|
3.1 |
|
3.9 |
|
2.9 |
|
3.7 |
|
2.5 |
|
3.3 |
|||||||
General and administrative |
|
1.2 |
|
1.5 |
|
1.2 |
|
1.5 |
|
1.1 |
|
1.4 |
|
1.0 |
|
1.3 |
|||||||
Sales and marketing |
|
0.5 |
|
0.7 |
|
0.5 |
|
0.7 |
|
0.4 |
|
0.6 |
|
0.4 |
|
0.6 |
|||||||
Total |
$ |
7.3 |
$ |
9.3 |
$ |
7.1 |
$ |
9.1 |
$ |
6.6 |
$ |
8.6 |
$ |
5.8 |
$ |
7.8 |
|||||||
|
|
|
|
|
|
|
|
|
Availability of Information on Expensify’s Website
Investors and others should note that
Conference Call
Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with
We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.
Adjusted EBITDA. We define adjusted EBITDA as net loss from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization, and stock-based compensation.
Non-GAAP net income. We define non-GAAP net income as net loss from operations excluding stock-based compensation.
Free cash flow. We define Free cash flow as net cash provided by operating activities excluding changes in settlement assets and settlement liabilities, which represent funds held for customers and customer funds in transit, respectively, reduced by the purchases of property and equipment and software development costs.
The tables at the end of the Condensed Consolidated Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.
Forward-Looking Statements
Forward-looking statements in this press release, or made during the earnings call, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, future cash flow, projected costs, prospects, plans, objectives of management and expected market growth, product developments and their potential impact and our stock-based compensation estimates and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “ambition,” “objective,” “seeks,” “outlook,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the impact on inflation on us and our members; our borrowing costs have and may continue to increase as a result of increases in interest rates; our expectations regarding our financial performance and future operating performance; our ability to attract and retain members, expand usage of our platform, sell subscriptions to our platform and convert individuals and organizations into paying customers; the timing and success of new features, integrations, capabilities and enhancements by us, or by competitors to their products, or any other changes in the competitive landscape of our market; the amount and timing of operating expenses and capital expenditures that we may incur to maintain and expand our business and operations to remain competitive; the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs; our ability to make required payments under and to comply with the various requirements of our current and future indebtedness; our cash flows, the prevailing stock prices, general economic and market conditions and other considerations that could affect the specific timing, price and size of repurchases under our stock repurchase program or our ability to fund any stock repurchases; geopolitical tensions, including the war in
About
|
|||||||
Condensed Consolidated Balance Sheets |
|||||||
(unaudited, in thousands, except share data) |
|||||||
|
|||||||
|
As of |
As of |
|||||
|
2024 |
2023 |
|||||
Assets |
|
|
|||||
Cash and cash equivalents |
$ |
53,234 |
|
$ |
47,510 |
|
|
Accounts receivable, net |
|
13,420 |
|
|
13,834 |
|
|
Settlement assets, net |
|
48,301 |
|
|
39,261 |
|
|
Prepaid expenses |
|
8,768 |
|
|
5,649 |
|
|
Other current assets |
|
32,044 |
|
|
30,978 |
|
|
Total current assets |
|
155,767 |
|
|
137,232 |
|
|
Capitalized software, net |
|
16,006 |
|
|
12,494 |
|
|
Property and equipment, net |
|
13,905 |
|
|
14,372 |
|
|
Lease right-of-use assets |
|
5,783 |
|
|
6,435 |
|
|
Deferred tax assets, net |
|
487 |
|
|
457 |
|
|
Other assets |
|
924 |
|
|
5,794 |
|
|
Total assets |
$ |
192,872 |
|
$ |
176,784 |
|
|
Liabilities and stockholders' equity |
|
|
|||||
Accounts payable |
$ |
1,022 |
|
$ |
1,425 |
|
|
Accrued expenses and other liabilities |
|
7,853 |
|
|
9,390 |
|
|
Borrowings under line of credit |
|
15,000 |
|
|
15,000 |
|
|
Current portion of long-term debt, net of original issue discount and debt issuance costs |
|
7,592 |
|
|
7,655 |
|
|
Lease liabilities, current |
|
461 |
|
|
432 |
|
|
Settlement liabilities |
|
38,877 |
|
|
33,990 |
|
|
Total current liabilities |
|
70,805 |
|
|
67,892 |
|
|
Lease liabilities, non-current |
|
6,118 |
|
|
6,467 |
|
|
Other liabilities |
|
1,949 |
|
|
1,681 |
|
|
Total liabilities |
|
78,872 |
|
|
76,040 |
|
|
Commitments and contingencies |
|
|
|||||
Stockholders' equity: |
|
|
|||||
Preferred stock, par value |
|
— |
|
|
— |
|
|
Common stock, par value |
|
9 |
|
|
8 |
|
|
Additional paid-in capital |
|
261,309 |
|
|
241,509 |
|
|
Accumulated deficit |
|
(147,318 |
) |
|
(140,773 |
) |
|
Total stockholders' equity |
|
114,000 |
|
|
100,744 |
|
|
Total liabilities and stockholders' equity |
$ |
192,872 |
|
$ |
176,784 |
|
|
|||||||||||||||
Condensed Consolidated Statements of Operations |
|||||||||||||||
(unaudited, in thousands, except share and per share data) |
|||||||||||||||
|
|||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||
|
2024 |
2023 |
2024 |
2023 |
|||||||||||
Revenue |
$ |
33,288 |
|
$ |
38,884 |
|
$ |
66,823 |
|
$ |
78,985 |
|
|||
Cost of revenue, net (1) |
|
14,363 |
|
|
16,925 |
|
|
28,947 |
|
|
32,700 |
|
|||
Gross margin |
|
18,925 |
|
|
21,959 |
|
|
37,876 |
|
|
46,285 |
|
|||
Operating expenses: |
|
|
|
|
|||||||||||
Research and development (1) |
|
6,389 |
|
|
5,094 |
|
|
12,318 |
|
|
10,512 |
|
|||
General and administrative (1) |
|
9,245 |
|
|
11,712 |
|
|
20,676 |
|
|
24,141 |
|
|||
Sales and marketing (1) |
|
3,072 |
|
|
14,714 |
|
|
6,456 |
|
|
23,897 |
|
|||
Total operating expenses |
|
18,706 |
|
|
31,520 |
|
|
39,450 |
|
|
58,550 |
|
|||
Income (loss) from operations |
|
219 |
|
|
(9,561 |
) |
|
(1,574 |
) |
|
(12,265 |
) |
|||
Interest and other expenses, net |
|
(260 |
) |
|
(1,367 |
) |
|
(1,214 |
) |
|
(2,783 |
) |
|||
Loss before income taxes |
|
(41 |
) |
|
(10,928 |
) |
|
(2,788 |
) |
|
(15,048 |
) |
|||
Provision for income taxes |
|
(2,723 |
) |
|
(376 |
) |
|
(3,757 |
) |
|
(2,201 |
) |
|||
Net loss |
$ |
(2,764 |
) |
$ |
(11,304 |
) |
$ |
(6,545 |
) |
$ |
(17,249 |
) |
|||
Net loss per share: |
|
|
|
|
|||||||||||
Basic and diluted |
$ |
(0.03 |
) |
$ |
(0.14 |
) |
$ |
(0.08 |
) |
$ |
(0.21 |
) |
|||
Weighted average shares of common stock used to compute net loss per share: |
|
|
|
|
|||||||||||
Basic and diluted |
|
86,593,955 |
|
|
82,011,477 |
|
|
85,867,683 |
|
|
81,890,624 |
|
|||
|
|
|
|
|
(1) Includes stock-based compensation expense as follows: |
|||||||||||
|
Three Months Ended |
Six months ended |
|||||||||
|
2024 |
2023 |
2024 |
2023 |
|||||||
Cost of revenue, net |
$ |
2,886 |
$ |
3,600 |
$ |
5,818 |
$ |
6,906 |
|||
Research and development |
|
3,144 |
|
2,455 |
|
5,894 |
|
4,661 |
|||
General and administrative |
|
1,703 |
|
2,376 |
|
3,405 |
|
5,020 |
|||
Sales and marketing |
|
648 |
|
1,910 |
|
788 |
|
3,758 |
|||
Total stock-based compensation expense |
$ |
8,381 |
$ |
10,341 |
$ |
15,905 |
$ |
20,345 |
|||
|
|
|
|
|
|
|||||||
Condensed Consolidated Statements of Cash Flows |
|||||||
(unaudited, in thousands) |
|||||||
|
|||||||
|
Six Months Ended |
||||||
|
2024 |
2023 |
|||||
Cash flows from operating activities: |
|
|
|||||
Net loss |
$ |
(6,545 |
) |
$ |
(17,249 |
) |
|
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|||||
Depreciation and amortization |
|
3,053 |
|
|
2,789 |
|
|
Reduction of operating lease right-of-use assets |
|
273 |
|
|
334 |
|
|
Loss on impairment, receivables and sale or disposal of equipment |
|
537 |
|
|
402 |
|
|
Stock-based compensation expense |
|
15,905 |
|
|
20,345 |
|
|
Amortization of original issue discount and debt issuance costs |
|
28 |
|
|
49 |
|
|
Deferred tax assets |
|
(30 |
) |
|
(65 |
) |
|
Changes in assets and liabilities: |
|
|
|||||
Accounts receivable, net |
|
175 |
|
|
1,358 |
|
|
Settlement assets, net |
|
(7,876 |
) |
|
(5,244 |
) |
|
Prepaid expenses |
|
1,831 |
|
|
3,775 |
|
|
Other current assets |
|
1,838 |
|
|
(952 |
) |
|
Other assets |
|
(80 |
) |
|
(88 |
) |
|
Accounts payable |
|
(425 |
) |
|
632 |
|
|
Accrued expenses and other liabilities |
|
(1,105 |
) |
|
2,670 |
|
|
Operating lease liabilities |
|
54 |
|
|
(294 |
) |
|
Settlement liabilities |
|
4,887 |
|
|
(1,382 |
) |
|
Other liabilities |
|
268 |
|
|
128 |
|
|
Net cash provided by operating activities |
|
12,788 |
|
|
7,208 |
|
|
Cash flows from investing activities: |
|
|
|||||
Purchases of property and equipment |
|
— |
|
|
(479 |
) |
|
Software development costs |
|
(4,867 |
) |
|
(2,043 |
) |
|
Net cash used in investing activities |
|
(4,867 |
) |
|
(2,522 |
) |
|
Cash flows from financing activities: |
|
|
|||||
Principal payments of finance leases |
|
(63 |
) |
|
(404 |
) |
|
Principal payments of outstanding debt |
|
(75 |
) |
|
(8,300 |
) |
|
Payments for debt issuance costs |
|
(71 |
) |
|
— |
|
|
Repurchases of early exercised stock options |
|
(32 |
) |
|
(13 |
) |
|
Proceeds from common stock purchased under Matching Plan |
|
2,004 |
|
|
2,076 |
|
|
Proceeds from issuance of common stock on exercise of stock options |
|
53 |
|
|
125 |
|
|
Payments for employee taxes withheld from stock-based awards |
|
— |
|
|
(1,524 |
) |
|
Repurchase and retirement of common stock |
|
— |
|
|
(3,000 |
) |
|
Net cash provided by (used in) financing activities |
|
1,816 |
|
|
(11,040 |
) |
|
Net increase (decrease) in cash and cash equivalents and restricted cash |
|
9,737 |
|
|
(6,354 |
) |
|
Cash and cash equivalents and restricted cash, beginning of period |
|
96,658 |
|
|
147,710 |
|
|
Cash and cash equivalents and restricted cash, end of period |
$ |
106,395 |
|
$ |
141,356 |
|
|
Supplemental disclosure of cash flow information: |
|
|
|||||
Cash paid for interest |
$ |
903 |
|
$ |
2,912 |
|
|
Cash paid for income taxes |
$ |
2,439 |
|
$ |
2,251 |
|
|
Noncash investing and financing items: |
|
|
|||||
Stock-based compensation capitalized as software development costs |
$ |
1,561 |
|
$ |
1,399 |
|
|
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses |
$ |
290 |
|
$ |
373 |
|
|
Right-of-use assets acquired through operating leases |
$ |
— |
|
$ |
6,402 |
|
|
Reconciliation of cash and cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets |
|
|
|||||
Cash and cash equivalents |
$ |
53,234 |
|
$ |
97,795 |
|
|
Restricted cash included in other current assets |
|
30,591 |
|
|
20,986 |
|
|
Restricted cash included in settlement assets, net |
|
22,570 |
|
|
22,575 |
|
|
Total cash, cash equivalents and restricted cash |
$ |
106,395 |
|
$ |
141,356 |
|
|
|
|
|
|
|||||||
Reconciliation of GAAP to Non-GAAP Financial Measures |
|||||||
(unaudited, in thousands, except percentages) |
|||||||
|
|||||||
Adjusted EBITDA and Adjusted EBITDA Margin |
|||||||
|
Three Months Ended |
||||||
|
2024 |
2023 |
|||||
Net loss |
$ |
(2,764 |
) |
$ |
(11,304 |
) |
|
Net loss margin |
|
(8 |
)% |
|
(29 |
)% |
|
Add: |
|
|
|||||
Provision for income taxes |
|
2,723 |
|
|
376 |
|
|
Interest and other expenses, net |
|
260 |
|
|
1,367 |
|
|
Depreciation and amortization |
|
1,590 |
|
|
1,376 |
|
|
Stock-based compensation |
|
8,381 |
|
|
10,341 |
|
|
Adjusted EBITDA |
$ |
10,190 |
|
$ |
2,156 |
|
|
Adjusted EBITDA margin |
|
31 |
% |
|
6 |
% |
|
|
|
|
Non-GAAP Net Income and Non-GAAP Net Income Margin |
|||||||
|
Three Months Ended |
||||||
|
2024 |
2023 |
|||||
Net loss |
$ |
(2,764 |
) |
$ |
(11,304 |
) |
|
Net loss margin |
|
(8 |
)% |
|
(29 |
)% |
|
Add: |
|
|
|||||
Stock-based compensation |
|
8,381 |
|
|
10,341 |
|
|
Non-GAAP net income (loss) |
$ |
5,617 |
|
$ |
(963 |
) |
|
Non-GAAP net income (loss) margin |
|
17 |
% |
|
(2 |
)% |
|
|
|
|
Adjusted Operating Cash Flow and Free Cash Flow |
|||||||||||
|
Three Months Ended |
Three Months Ended |
|||||||||
|
2024 |
2023 |
2024 |
||||||||
Net cash provided by (used in) operating activities |
$ |
9,317 |
|
$ |
(434 |
) |
$ |
3,471 |
|
||
Operating cash flow margin |
|
28 |
% |
|
(1 |
)% |
|
10 |
% |
||
(Increase) decrease in changes in assets and liabilities: |
|
|
|
||||||||
Settlement assets |
|
1,756 |
|
|
2,561 |
|
|
6,120 |
|
||
Settlement liabilities |
|
(3,317 |
) |
|
644 |
|
|
(1,570 |
) |
||
Adjusted operating cash flow |
|
7,756 |
|
|
2,771 |
|
|
8,021 |
|
||
Less: |
|
|
|
||||||||
Purchases of property and equipment |
|
— |
|
|
(451 |
) |
|
— |
|
||
Software development costs |
|
(2,038 |
) |
|
(1,173 |
) |
|
(2,829 |
) |
||
Free cash flow |
$ |
5,718 |
|
$ |
1,147 |
|
$ |
5,192 |
|
||
Free cash flow margin |
|
17 |
% |
|
3 |
% |
|
15 |
% |
||
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20240808698155/en/
Investor Relations Contact
investors@expensify.com
Press Contact
press@expensify.com
Source: